Each compound has different characteristics, and only by selecting the characteristics of the compound suitable for a specific situation can the compound be applied on a large scale. 619331-71-4, name is 4,7-Dibromo-1H-pyrrolo[2,3-c]pyridine. This compound has unique chemical properties. The synthetic route is as follows. SDS of cas: 619331-71-4
A mixture of 4,7-dibromo-lH-pyrrolo[2,3-c]pyridine (946 mg, 3.43 mmol), Nal (2.08 g, 13.7 mmol), Cul (33 mg, 0.17 mmol), and trans-N,N’-dimethylcyclohexane-l, 2-diamine (51 mg, (1779) 0.35 mmol) in l,4-dioxane (10 mL) was stirred at 90 C under argon for 4 h. LC/MS showed complete conversion was achieved (LC-MS 323.0, 325.0 [M+H]+, RT 1.30 min). The solvent was removed and the residue was suspended in ethyl acetate and filtered. The filtrate was washed with NH4CI (aq.), water and brine, dried over anhydrous Na2S04 and concentrated. The material obtained was dissolved in dichloromethane (20 mL) and treated with di-tert-butyl dicarbonate (1.20 mL, 5.1 mmol) and a few crystals of 4-dimethylaminopyridine. After stirring at room temperature for 2 h, the mixture was concentrated and chromatographed on a silica gel column (ethyl acetate in hexames, 0 – 50%) to provide tert-butyl 4-bromo-7-iodo-pyrrolo[2,3-c]pyridine- l-carboxylate (1.41 g, 97%) as a pink oil. LC-MS 423.3, 425.3 [M+H]+, RT 1.69 min.
If you are interested in these compounds, you can also browse my other articles.Thank you for taking the time to read this article. I hope you enjoyed it, 619331-71-4, 4,7-Dibromo-1H-pyrrolo[2,3-c]pyridine.
Reference:
Patent; PTC THERAPEUTICS, INC.; CHEN, Guangming; BHATTACHARYYA, Anuradha; JIANG, Yao; KARP, Gary, Mitchell; NARASIMHAN, Jana; TURPOFF, Anthony; ZHANG, Nanjing; (0 pag.)WO2020/5882; (2020); A1;,
Pyridine – Wikipedia,
Pyridine | C5H5N – PubChem